Dr. Upal Roy

University of Texas Rio Grande Valley, UTRGV, USA

Email: [email protected]

Qualifications

2005  Ph.D., Goa University, India

1999  M.S., Marathwada University, India

1997  B.S., Marathwada University, India

Publications (selected)

1. Roy, U., Hadad, R., Rodriguez, A. A., et al. (2025). Effects of Space Flight on Inflammasome Activation in the Brain of Mice. Cells, 14(6), Article 417.
2. Kamkwalala, A. R., Matthews, A., Garg, A., et al. (2025). The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases, 80(4), 871-880.
3. Vaiphei, K. K., Prabakaran, A., Singh, S., et al. (2024). Impact of PEGylated liposomes on cytotoxicity of tamoxifen and piperine on MCF-7 human breast carcinoma cells. Journal of Drug Delivery Science and Technology, 102, Article 106331.
4. Cecchetti, S., Roy, U., & Cavallo, M. (2024). From the Eyes to the Suffering Brain: Can Eye Tracking be Considered as a Significant Digital Biomarker for Neurological Diseases? Journal of Integrative Neuroscience, 23(9), Article 167.
5. Roy, D., Paul, A., Haney, M. J., et al. (2024). Development of a novel approach to treat HIV reservoirs in gut-associated lymphoid tissues using nanoformulation of cART drugs. Journal of the International AIDS Society, 27(SU 4), 8.
6. Alcalá-Zúniga, D., Espinoza-Torres, E., Das, R. K., et al. (2024). Enriched Environment Contributes to the Recovery from Neurotoxin-Induced Parkinson's Disease Pathology. Molecular Neurobiology, 61(9), 6734-6753.
7. Xu, C., Xiao, D. Q., Su, B. B., et al. (2024). Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer's disease: racial differences. Neurological Sciences, 45(3), 1041-1050.
8. Maestre, G., Carrillo, M., Kalaria, R., et al. (2023). The Nairobi Declaration-Reducing the burden of dementia in low- and middle-income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs. Alzheimer's & Dementia, 19(3), 1105-1108.
9. Garces, A., Martinez, B., de la Garza, R., et al. (2023). Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders. Scientific Reports, 13(1), Article 3276.
10. Das, R. K., Roy, D., Sahoo, N., et al. (2022). IFIT3 GENE EXPRESSION AND FUNCTION CONTRIBUTE TO HAND PATHOLOGY EVEN WITH ANTIRETROVIRAL THERAPIES (CARTS). Innovation in Aging, 6(SU 1), 843-844.
11. Garcia, C. R., Rad, A. T., Saeedinejad, F., et al. (2022). Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection. Nanomedicine, 17(13), 959-978.
12. Dethe, M. R., Prabakaran, A., Ahmed, H., et al. (2022). PCL-PEG copolymer based injectable thermosensitive hydrogels. Journal of Controlled Release, 343, 217-236.
13. Kamkwalala, A. R., Garg, A., Roy, U., et al. (2021). Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop. AIDS Research and Human Retroviruses, 37(11), 807-820.
14. Abshier, J., Roy, U., Drozd, V., et al. (2019). Development of Nanodiamond-based Anti-HIV Drug Delivery Targeted to the Brain. Journal of Neuroimmune Pharmacology, 14(2), 338.
15. Malhotra, P., Haslett, P., Sherry, B., et al. (2019). Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+T cell counts in HIV-1-infected Patients with a Suppressed Viral Load. Scientific Reports, 9, Article 5963.
16. De La Garza, R., Rodrigo, H., Fernandez, F., et al. (2019). The Increase of HIV-1 Infection, Neurocognitive Impairment , and Type 2 Diabetes in The Rio Grande Valley. Current HIV Research, 17(6), 377-387.
17. Roy, U., Drozd, V., Durygin, A., et al. (2018). Development of Nanodiamond-based anti-HIV drug delivery targeted to the Brain. Journal of Neuroimmune Pharmacology, 13(SU 1), S75.
18. Roy, U., Drozd, V., Durygin, A., et al. (2018). Development of Nanodiamond-based anti-HIV drug delivery targeted to the Brain. Journal of Neurovirology, 24(SU 1), S75.
19. Roy, U., Drozd, V., Durygin, A., et al. (2018). Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain. Scientific Reports, 8, Article 1603.
20. Kaushik, A., Jayant, R. D., Nikkhah-Moshaie, R., et al. (2016). Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Scientific Reports, 6, Article 25309.

profiles Details
https://www.utrgv.edu/biochemistry-molecular-biology-ms/_files/documents/proffesors_cv/cv_upal_roy.pdf
https://scholar.google.com/citations?user=Vmq-qkQAAAAJ&hl=en
https://www.researchgate.net/scientific-contributions/Upal-Roy-2165893189

WOS ResearcherID: C-6126-2012